Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

DXCM

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

DXCM

AI Research Report

Powered by Claude

Ready to analyze DXCM

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

C+
Stonvex Quant Grade
50.0/ 100
Rank-normalised composite of 6 factors, updated every 60 seconds.
Volume
C+
50 / 100

Today's volume vs prior session average.

Volatility
C+
50 / 100

Absolute daily price move vs peers.

News Flow
C+
50 / 100

24h article count relative to the universe.

Sentiment
C+
50 / 100

AI-classified polarity of recent news.

Dollar Flow
C+
50 / 100

Today's dollar turnover (volume × VWAP).

Relative Strength
C+
50 / 100

Signed daily return vs the rest of the universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Similar stocks

View all Healthcare →
LLY
Eli Lilly
$810.50
+2.30%
UNH
UnitedHealth
$485.20
-2.51%
NVO
Novo Nordisk
—
—
JNJ
Johnson & Johnson
—
—
TMO
Thermo Fisher
—
—
WELL
Welltower
—
—
Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

Dexcom Inc

Dexcom Inc

Health Care·NASDAQ NMS - GLOBAL MARKET·US·IPO 2005-04-14
📅 Earnings in 16d (Apr 30)
  • ChartMill·1d ago

    Explore the top gainers and losers within the S&P500 index in today's session.

    Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

  • Yahoo·1d ago

    Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

    Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

  • ChartMill·4d ago

    DexCom Inc (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy

    DexCom (DXCM) exemplifies GARP investing, offering strong growth in glucose monitoring at a price reasonable relative to its industry and supported by robust profitability.

  • View all news →

Factor Grades

View details →
B-
Overall score: 64/100
C
Valuation
B+
Growth
B+
Profitability
D
Momentum
A-
Financial Health

Recent insider activity

View all →
  • 4FORM 4
    27d ago
  • 4FORM 4
    Mar 10
  • 4FORM 4
    Mar 10
  • 4FORM 4
    Mar 10
  • 4FORM 4
    Mar 10
NASDAQ NMS - GLOBAL MARKETAfter-hours
Dexcom Inc
Health Care
—
— (—)
Open
—
Prev close
—
Day range
— – —
52W range
$54.11 – $89.98
Mkt cap
$24.29B
P/E
29.1
EPS
$2.07
Beta
1.52

Fundamentals

Valuation
Market Cap
$24.29B
P/E (TTM)
29.11S&P avg ~22
P/S (TTM)
5.22S&P avg ~2.8
P/B
9.43S&P avg ~4.5
P/FCF
22.60S&P avg ~26
EPS (TTM)
$2.07
Book/sh
$7.14
Cash/sh
$5.19
Profitability
Gross Margin
62.09%avg ~45%
Operating Margin
19.56%avg ~15%
Net Margin
17.94%avg ~12%
ROE
32.44%avg ~18%
ROA
11.98%avg ~7%
ROI
17.50%
Payout Ratio
—
FCF/sh
—
Growth & Health
Rev Growth YoY
15.60%
Rev Growth 5Y
19.33%
EPS Growth YoY
47.91%
EPS Growth 5Y
9.54%
Current Ratio
—
Quick Ratio
1.56
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
1.52
52W High
$89.98
52W Low
$54.11
Avg Vol (10D)
3.53M
Avg Vol (3M)
4.81M
Div Yield
—
Div/sh (TTM)
—
Analyst
Buy (37)
Price Performance
5D+0.02%
MTD+0.51%
3M-7.76%
6M-4.88%
YTD-4.90%
1Y-6.21%